Interstitial	JJ
fibrosis	NN
and	CC
growth	NN
factors	NNS
.	.

Interstitial	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
scarring	NN
of	IN
the	DT
lung	NN
caused	VBN
by	IN
a	DT
variety	NN
of	IN
inhaled	VBN
agents	NNS
including	VBG
mineral	NN
particles	NNS
,	,
organic	JJ
dusts	NNS
,	,
and	CC
oxidant	JJ
gases	NNS
.	.

The	DT
disease	NN
afflicts	VBZ
millions	NNS
of	IN
individuals	NNS
worldwide	RB
,	,
and	CC
there	EX
are	VBP
no	DT
effective	JJ
therapeutic	JJ
approaches	NNS
.	.

A	DT
major	JJ
reason	NN
for	IN
this	DT
lack	NN
of	IN
useful	JJ
treatments	NNS
is	VBZ
that	IN
few	JJ
of	IN
the	DT
molecular	JJ
mechanisms	NNS
of	IN
disease	NN
have	VBP
been	VBN
defined	VBN
sufficiently	RB
to	TO
design	VB
appropriate	JJ
targets	NNS
for	IN
therapy	NN
.	.

Our	PRP$
laboratory	NN
has	VBZ
focused	VBN
on	IN
the	DT
molecular	JJ
mechanisms	NNS
through	IN
which	WDT
three	CD
selected	VBN
peptide	NN
growth	NN
factors	NNS
could	MD
play	VB
a	DT
role	NN
in	IN
the	DT
development	NN
of	IN
IPF	NN
.	.

Hundreds	NNS
of	IN
growth	NN
factors	NNS
and	CC
cytokines	NNS
could	MD
be	VB
involved	VBN
in	IN
the	DT
complex	NN
disease	NN
process	NN
.	.

We	PRP
are	VBP
studying	VBG
platelet-derived	JJ
growth	NN
factor	NN
because	IN
it	PRP
is	VBZ
the	DT
most	RBS
potent	JJ
mesenchymal	JJ
cell	NN
mitogen	NN
yet	RB
described	VBN
,	,
transforming-growth-factor-beta	NN
because	IN
it	PRP
is	VBZ
a	DT
powerful	JJ
inducer	NN
of	IN
extracellular	JJ
matrix	NN
(	(
scar	NN
tissue	NN
)	)
components	NNS
by	IN
mesenchymal	JJ
cells	NNS
,	,
and	CC
tumor-necrosis-factor-alpha	NN
because	IN
it	PRP
is	VBZ
a	DT
pleiotropic	JJ
cytokine	NN
that	IN
we	PRP
and	CC
others	NNS
have	VBP
shown	VBN
is	VBZ
essential	JJ
for	IN
the	DT
development	NN
of	IN
IPF	NN
in	IN
animal	NN
models	NNS
.	.

This	DT
review	NN
describes	VBZ
some	DT
of	IN
the	DT
evidence	NN
from	IN
studies	NNS
in	IN
humans	NNS
,	,
in	IN
animal	NN
models	NNS
,	,
and	CC
in	FW
vitro	FW
,	,
that	IN
supports	VBZ
the	DT
growth	NN
factor	NN
hypothesis	NN
.	.

The	DT
use	NN
of	IN
modern	JJ
molecular	JJ
and	CC
transgenic	JJ
technologies	NNS
could	MD
elucidate	VB
those	DT
targets	NNS
that	WDT
will	MD
allow	VB
effective	JJ
therapeutic	JJ
approaches	NNS
.	.

